Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Basal Cell Cancer
Scientists at University of Florence publish research in basal cell cancer
May 19th, 2009
In this recently published study, investigators in Florence, Italy conducted a study "To evaluate retrospectively the long-term results of methyl aminoeluvinate photodynamic therapy for the treatment of eyelid basal cell carcinoma. Sixteen consecutive patients with eyelid basal cell carcinoma were treated with methyl aminoeluvinate photodynamic therapy between January 2002 and April 2003." "Selection criteria were tumors located at least 3 mm from the tarsus, surgery not indicated because of poor general health, and recurrences with unclear location definition. Patients were treated with an 80-J cm(2) light-emitting diode light source (632 nm) after topical application...
Source: Cancer Weekly (2009-05-19)
|
